Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 22 Vitamin D Deficiency 20 Prostatic Neoplasms 17 Polycystic Ovary Syndrome 10 Neoplasms 9 Colonic Neoplasms 8 Rectal Neoplasms 6 Colorectal Neoplasms 6 Osteoporosis 5 Myelodysplastic Syndromes 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Cardiovascular Diseases 4 Warts 3 Ovarian Neoplasms 3 Leukemia, Myeloid, Acute 3 Leukemia 3 Brain Neoplasms 3 Adenomatous Polyps 3 Pathologic Processes 2 Pain 2 Obesity 2 Myeloproliferative Disorders 2 Myelodysplastic-Myeloproliferative Diseases 2 Musculoskeletal Diseases 2 Melanoma 2 Male Urogenital Diseases 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2

Interventions

relacorilant 5 Pioglitazone 4 Metformin 4 Sitagliptin Phosphate 3 Resistance Training 3 Dipeptidyl-Peptidase IV Inhibitors 3 saxagliptin 2 Vildagliptin 2 Sulfonylurea Compounds 2 Rosiglitazone 2 Nutritional Status 2 Blood Specimen Collection 2 voglibose 1 somapacitan 1 semaglutide 1 repaglinide 1 pembrolizumab 1 miglitol 1 metahexamide 1 meglitinide 1 mazdutide 1 glymidine 1 glisoxepide 1 gliquidone 1 glimepiride 1 glibornuride 1 empagliflozin 1 dapagliflozin 1 alogliptin 1 Urine Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Diabetes Mellitus, Type 2 × Cholecalciferol × Clear all

NCT01463813 2018-10-23

FIND

University of Eastern Finland

Phase NA Completed

Cardiovascular Diseases, Diabetes Mellitus, Type 2, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡